[EN] 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS<br/>[FR] ANALOGUES DE PYRIDAZINE 1,4-DISUBSTITUÉE ET PROCÉDÉS DE TRAITEMENT DE TROUBLES LIÉS À UNE DÉFICIENCE EN SMN
申请人:NOVARTIS AG
公开号:WO2014028459A1
公开(公告)日:2014-02-20
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
申请人:NOVARTIS AG
公开号:US20170290828A1
公开(公告)日:2017-10-12
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof;
a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
申请人:Axford Jake
公开号:US09040712B2
公开(公告)日:2015-05-26
The present invention provides a compound of Formula (X) or a pharmaceutically acceptable salt thereof;
a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
申请人:Cheung Atwood Kim
公开号:US08729263B2
公开(公告)日:2014-05-20
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof;
a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
THIADIAZOLE ANALOGS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH A DEFICIENCY OF SMN MOTOR NEURONS
申请人:Novartis AG
公开号:EP3736271A1
公开(公告)日:2020-11-11
The present invention provides a compound of Formula (X) or a pharmaceutically acceptable salt thereof;
a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.